Ritholtz Wealth Management Has $346,000 Stock Position in LifeVantage Co. (NASDAQ:LFVN)

Ritholtz Wealth Management increased its stake in LifeVantage Co. (NASDAQ:LFVN) by 62.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,666 shares of the company’s stock after buying an additional 10,974 shares during the quarter. Ritholtz Wealth Management owned approximately 0.23% of LifeVantage worth $346,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Hillsdale Investment Management Inc. acquired a new stake in LifeVantage in the first quarter valued at $76,000. Hantz Financial Services Inc. bought a new position in LifeVantage during the second quarter worth about $91,000. Empowered Funds LLC increased its position in LifeVantage by 8.1% during the first quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after buying an additional 5,742 shares during the last quarter. Acadian Asset Management LLC raised its stake in LifeVantage by 2.8% in the first quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after buying an additional 6,121 shares during the period. Finally, Vanguard Group Inc. raised its stake in LifeVantage by 2.8% in the first quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock valued at $2,874,000 after buying an additional 12,809 shares during the period. 35.32% of the stock is owned by institutional investors.

LifeVantage Trading Down 0.7 %

Shares of NASDAQ LFVN opened at $11.84 on Thursday. The company has a market capitalization of $150.38 million, a P/E ratio of 42.29 and a beta of 0.84. LifeVantage Co. has a 12 month low of $4.20 and a 12 month high of $13.71. The stock has a 50 day moving average of $9.92 and a 200-day moving average of $7.89.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.07). The company had revenue of $48.93 million for the quarter. LifeVantage had a return on equity of 27.85% and a net margin of 1.47%.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Shareholders of record on Monday, September 9th were given a dividend of $0.04 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 annualized dividend and a yield of 1.35%. LifeVantage’s dividend payout ratio (DPR) is presently 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.